Medical dictionary
Medical terminology normalized via MeSH, ICD-11, SNOMED CT.
62,341 terms indexed
prodrug that releases both PP2 (4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo(3,4-d)pyrimidine), a c-Src kinase inhibitor, and AL621; structure in first source
RefSeq NM_001102446
an MCH1 antagonist
RefSeq NM_028270
structure in first source
RefSeq NM_001161233
a carbon monoxide-releasing compound with antimalarial activity; structure in first source
RefSeq NM_001202573
RefSeq NM_182192
RefSeq NM_120319
RefSeq NM_001142357
RefSeq NM_018466
a DNA dioxygenase; RefSeq NM_127792
RefSeq NM_028070
RefSeq NM_017758
RefSeq NM_172943
RefSeq NM_001077387
RefSeq NM_032306
RefSeq NM_103320
also a malate transporter; RefSeq NM_112729
ALN-PCSsc is administered subcutaneously; interferes with synthesis of proprotein convertase subtilisin kexin type 9
RefSeq NM_001256153
RefSeq NM_052947
consists of interleukin-2 linked to a soluble, single-chain T-cell receptor domain that recognizes a p53 epitope
an anti-tissue factor IgG4kappa chimeric antibody
a mixture of two proteases, EP-B2 (ALV001) and SC PEP (ALV002) that degrades gluten
a fully human antibody that binds to the protective antigen of anthrax toxin from a Fab isolated from a phage display library
thrombopoietin (TPO) receptor agonist lacking sequence homology to TPO designed by grafting a known peptide sequence into the hinge and/or kappa constant regions of a human anti-anthrax antibody, ALXN4100
an antithrombotic nanobody constructed from two PMP12A2h1 building blocks, genetically linked to each other with a 3 alanine linker
DP2 receptor antagonist; structure in first source
structure in first source
RefSeq NM_152704
RefSeq NM_001105193
an anti-inflammatory agent; structure in first source
CD33/CD3-directed bispecific T-cell engager antibody
BAFF-specific inhibitor that reduces B-cell number and improves outcomes in murine models of autoimmune disease
AMIGO - amphoterin-induced gene and ORF; RefSeq NM_001004293
RefSeq NM_020703
An enzyme that catalyzes the deamination of AMP to IMP. EC 3.5.4.6.
Intracellular signaling protein kinases that play a signaling role in the regulation of cellular energy metabolism. Their activity largely depends upon the concentration of cellular AMP which is increased under conditions of low energy or metabolic stress. AMP-activated protein kinases modify enzymes involved in LIPID METABOLISM, which in turn provide substrates needed to convert AMP into ATP.
a naphthyl derivative of 2-cyanoaziridine-1-carboxamide; structure in first source
RefSeq NM_001033303
RefSeq NM_001276301
RefSeq NM_103774
RefSeq NM_148342